Not too much new in the results other than the sales pipeline remains strong in the 2H. The funding from the Alzheimer's Drug Discovery Fund is interesting although it is not very clear how much we need to commit and ultimately where/how it get commercialized.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.70 |
Change
-0.050(2.86%) |
Mkt cap ! $287.1M | |||
| Open | High | Low | Value | Volume |
| $1.75 | $1.75 | $1.70 | $69.18K | 40.43K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3915 | $1.68 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.74 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 02/07/2025 (20 minute delay) ? |
| CGS (ASX) Chart |